kaal:position:2026-07-31-1277

Evidence that renal arterial-venous oxygen shunting contributes to dynamic regulation of renal oxygenation. should be assessed against Kaal's source-bound claim that Companies that received venture capital investments have outrun and continue to outrun regulation and regulatory efforts, and they drive innovation trends in the United States and abroad. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

venture-capital-backed companies in the United States and abroad, 2005 through 2015
External evidence level: metadata only.
Mapping review tier: mapping review before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Evidence that renal arterial-venous oxygen shunting contributes to dynamic regulation of renal oxygenation.

Scholarly basis

kaal:claim:2808132-050
Wulf A. Kaal, Erik P.M. Vermeulen, How to Regulate Disruptive Innovation - From Facts to Data (2016). SSRN: https://ssrn.com/abstract=2808132
Source PDF sha256: 3515f2317ed9c1d33ae55d70467cdf1f6c4e350065ea6a887d5d7619599ad7d2

Evidence and mapping

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.3294
Mapping ambiguous: true

Topics

innovationdynamic-regulationempirical-evidence

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0006 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 6b5603ee694adf95360000fa16c474ed56cb6711e8485bef8e2f33255af39b40
curl -s https://wulfkaal.github.io/positions/2026-07-31-1277.md | sha256sum